Northwest Biotherapeutics Inc (NWBO.OQ)
BRIEF-Northwest Biotherapeutics says will sell to investors about 7.4 mln shares at 50 cents per share
* Entered into agreements with two new institutional investors for direct offering with gross proceeds of $3.7 million
* Requires additional time for company and independent registered public accounting firm to complete review process Source text: http://1.usa.gov/1rSsMoe Further company coverage:
* On may 2, co and holders of co's series B warrants agreed to extend exercise period of series b warrants from may 2, 2016 to may 23, 2016 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
* Reached agreement with three parties, in regard to three combination treatments, for three cancers in three phase ii trials
LONDON, March 22 An investment trust launched less than a year ago by star fund manager Neil Woodford is increasing its focus on early-stage companies and abandoning near-term plans to raise more capital, it said on Tuesday, after its net asset value fell nearly 3 percent.
* Says requires additional time to complete its year end procedures
|Dendreon Corporation (DNDNQ.PK)||--||--|
|ImmunoCellular Therapeutics Ltd (IMUC.A)||$0.21||-0.01|
|Premier Veterinary Group PLC (PVGP.L)||150.00p||--|
|Oxford BioMedica plc (OXB.L)||4.12p||+0.04|
|Amgen, Inc. (AMGN.OQ)||$170.68||+3.01|
|Bristol-Myers Squibb Co (BMY.N)||$76.47||+1.41|
|Bristol-Myers Squibb Co (BMYMP.PK)||$1,231.90||--|
|Agenus Inc (AGEN.OQ)||$4.93||+0.09|
|Argos Therapeutics Inc (ARGS.OQ)||$6.46||+0.14|
|Prima BioMed Limited (PRR.AX)||$0.04||--|
Earnings vs. Estimates
Analyst Research Reports
Provider : ValuEngine, Inc.
Provider : Pechala's Reports
Northwest Biotherapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider : Reuters Investment Profile
Provider : Ford Investor Services, Inc.
Provider : GlobalData
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.